Relying on the core technology and experience accumulated over the years, Haotian Pharma is devoted to optimizing or redesigning the synthetic routes of small molecule drugs, providing new drug R&D enterprises with small molecule drug compounds or key intermediates that are of stable quality, up to the standard of impurities, cost-effective and fast delivery, so as to help them accelerate the process of new drug development and achieve commercial profitability more quickly. The company owns an API manufacturing plant built in compliance with the domestic GMP standard and has established a strict Quality Management System, which is capable to provide our customers with the service of R&D and manufacture of APIs or key intermediates in the clinical study stage and commercial production stage.

Haotian Pharma can meet the demands for rapid customized production from gram scale to commercially scale-up, and has become a long-term partner of many prominent domestic and foreign pharmaceutical companies and CRO companies.